Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.

O. Gregoriou, S. Konidaris, N. Vitoratos, Constantinos B. Papadias, I Papoulias, A. Chryssicopoulos

PubMed · 1998 · 20 citations · 0 references

Abstract

This study suggests that 1.25 mg CEE + 5 mg MA is effective in preventing hypoestrogenic side effects caused by GnRH-a, while the treatment of endometriosis is not impaired.